首页> 美国卫生研究院文献>Scientific Reports >Ambient Ultrafine Particle Ingestion Alters Gut Microbiota in Association with Increased Atherogenic Lipid Metabolites
【2h】

Ambient Ultrafine Particle Ingestion Alters Gut Microbiota in Association with Increased Atherogenic Lipid Metabolites

机译:摄入环境超细颗粒物可改变肠道菌群并增加致动脉粥样硬化脂质代谢产物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Ambient particulate matter (PM) exposure is associated with atherosclerosis and inflammatory bowel disease. Ultrafine particles (UFP, dp < 0.1–0.2 μm) are redox active components of PM. We hypothesized that orally ingested UFP promoted atherogenic lipid metabolites in both the intestine and plasma via altered gut microbiota composition. Low density lipoprotein receptor-null (Ldlr−/−) mice on a high-fat diet were orally administered with vehicle control or UFP (40 μg/mouse/day) for 3 days a week. After 10 weeks, UFP ingested mice developed macrophage and neutrophil infiltration in the intestinal villi, accompanied by elevated cholesterol but reduced coprostanol levels in the cecum, as well as elevated atherogenic lysophosphatidylcholine (LPC 18:1) and lysophosphatidic acids (LPAs) in the intestine and plasma. At the phylum level, Principle Component Analysis revealed significant segregation of microbiota compositions which was validated by Beta diversity analysis. UFP-exposed mice developed increased abundance in Verrocomicrobia but decreased Actinobacteria, Cyanobacteria, and Firmicutes as well as a reduced diversity in microbiome. Spearman’s analysis negatively correlated Actinobacteria with cecal cholesterol, intestinal and plasma LPC18:1, and Firmicutes and Cyanobacteria with plasma LPC 18:1. Thus, ultrafine particles ingestion alters gut microbiota composition, accompanied by increased atherogenic lipid metabolites. These findings implicate the gut-vascular axis in a atherosclerosis model.
机译:环境颗粒物(PM)暴露与动脉粥样硬化和炎性肠病有关。超细颗粒(UFP,dp <0.1-0.2μm)是PM的氧化还原活性成分。我们假设口服摄入的UFP会通过改变肠道菌群组成而促进肠道和血浆中的动脉粥样硬化脂质代谢产物。高脂饮食的低密度脂蛋白受体无效(Ldlr -/-)小鼠每周口服3天,与媒介物对照或UFP(40μg/小鼠/天)一起口服。 10周后,摄入UFP的小鼠肠绒毛中出现巨噬细胞和中性粒细胞浸润,伴随胆固醇升高,但盲肠中的前列腺素水平降低,以及肠中的动脉粥样硬化溶血磷脂酰胆碱(LPC 18:1)和溶血磷脂酸(LPA)升高。和血浆。在门级,主成分分析显示了微生物群组成的明显分离,这已通过Beta多样性分析得到了验证。暴露于UFP的小鼠在Verrocomicrobia中的丰度增加,但放线菌,蓝细菌和Firmicutes减少,微生物组多样性降低。 Spearman的分析显示放线菌与盲肠胆固醇,肠道和血浆LPC18:1呈负相关,而Firmicutes和蓝细菌与血浆LPC 18:1呈负相关。因此,摄入超细颗粒会改变肠道微生物群的组成,并伴有动脉粥样硬化脂质代谢产物的增加。这些发现暗示了动脉粥样硬化模型中的肠血管轴。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号